Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | ABT | JNJ |
|---|
| Close | 106.20 | 273.20 |
| Market Cap | $184B | $666B |
| 1M | +7.46% | +3.20% |
| P/E (TTM) | 39.1 | 41.3 |
| Forward P/E | 17.6 | 22.0 |
| P/E 5-Yr Percentile | 99 | 100 |
| P/S | 3.8 | 6.7 |
| P/B | 3.6 | 7.8 |
| Dividend Yield | 1.98% | 3.12% |
| Latest Quarter Revenue | $11.2B | $25.4B |
| Revenue YoY | +7.8% | +5.9% |
| Gross Margin | 56.2% | 68.1% |
| Latest Quarter EPS | 0.61 | 0.09 |
| Avg Post-Earnings Move | ±1.6% | ±0.6% |
| EPS Beat Rate | — | 1 / 1 |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.71% | 1.18% |
| 90-Day Net Insider Buying | −$46.9M | −$62.0M |
ABT · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
